Skip to main content
Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences logoLink to Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences
letter
. 2014 Jan;19(1):81.

Resveratrol may improve osseointegration of dental implants in type 2 diabetes mellitus patients

Saber Khazaei 1, Malih Sadat Firouzei 2, Parastoo Afghari 2, Mozafar Khazaei 3,
PMCID: PMC3963331  PMID: 24672572

Sir,

Diabetes mellitus refers to a number of metabolic disorders, which are caused by an increase in the level of fasting plasma glucose. Type 2 diabetes mellitus (T2DM) can affect the bone, which causes osteopenia and impairs the healing of fractures.[1]

Dental implants have been recognized as an acceptable treatment method for the replacement of missing teeth. This treatment is highly related to bone mass. Any changes in the rates of formation and resorption that result in bone resorption over-stepping bone formation can cause a decrease in this mass resulting in implant failure, which is the case in T2DM patients. Diabetes has become the most common factor contributing to dental implants failure.[2]

Resveratrol (RSV) is a phytoalexin present in grapes, wines and peanuts, It has been reported to exhibit a wide range of biological and pharmacological properties that regulates several metabolic pathways.[3] RSV has a direct effect on bone formation and increases osteogenesis.[4,5] In addition RSV has anti-inflammatory and analgesic effects.[6,7]

In T2DM patients, the rate of osseointegration around dental implant decreases remarkably due to negative effect on different stages of osseointegration such as formation of bone matrix, bone apposition mineralization (through reduction of osteoblasts and alkaline phosphates activity) and maintenance of osseointegration.[8] Osteoblast maturation is assessed by these items including, alkaline phosphates activity, calcium deposition in the extracellular matrix, Osterix and Osteocalcin genes. RSV increases expression of these genes, which is associated with osteoblastic differentiation and also increases the expression of alkaline phosphates and prolyl hydroxylase in a dose-dependent manner.[9] It also enhances the differentiation of osteoblasts from mesenchymal stem cells.[4] RSV is a potent inhibitor of inflammatory molecules and has an inhibitory effect on the production of tumor necrosis factor α, IL-1, IL-6, IL-12 and Interferon (IFN) by macrophages and splenic lymphocytes.[10]

Considering the effect of hyperglycemia causing negative effect on bone formation and inflammatory effects in T2DM patients, which may result in reduced osseointegration and higher failure rate of dental implants, we hypothesize that RSV may reduce dental implant failure rate by having stimulating bone formation and anti-inflammatory effects. It seems that induction of RSV either by systemic or local delivery can improve osseointegration of dental implant in T2DM patients, further studies are deserved to prove our hypothesis.

REFERENCES

  • 1.Wang B, Song Y, Wang F, Li D, Zhang H, Ma A, et al. Effects of local infiltration of insulin around titanium implants in diabetic rats. Br J Oral Maxillofac Surg. 2011;49:225–9. doi: 10.1016/j.bjoms.2010.03.006. [DOI] [PubMed] [Google Scholar]
  • 2.Kotsovilis S, Karoussis IK, Fourmousis I. A comprehensive and critical review of dental implant placement in diabetic animals and patients. Clin Oral Implants Res. 2006;17:587–99. doi: 10.1111/j.1600-0501.2005.01245.x. [DOI] [PubMed] [Google Scholar]
  • 3.Harikumar KB, Aggarwal BB. Resveratrol: A multitargeted agent for age-associated chronic diseases. Cell Cycle. 2008;7:1020–35. doi: 10.4161/cc.7.8.5740. [DOI] [PubMed] [Google Scholar]
  • 4.Dai Z, Li Y, Quarles LD, Song T, Pan W, Zhou H, et al. Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine. 2007;14:806–14. doi: 10.1016/j.phymed.2007.04.003. [DOI] [PubMed] [Google Scholar]
  • 5.Zhou H, Shang L, Li X, Zhang X, Gao G, Guo C, et al. Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells. Exp Cell Res. 2009;315:2953–62. doi: 10.1016/j.yexcr.2009.07.030. [DOI] [PubMed] [Google Scholar]
  • 6.Bhat KP, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Ann N Y Acad Sci. 2002;957:210–29. doi: 10.1111/j.1749-6632.2002.tb02918.x. [DOI] [PubMed] [Google Scholar]
  • 7.Zykova TA, Zhu F, Zhai X, Ma WY, Ermakova SP, Lee KW, et al. Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol Carcinog. 2008;47:797–805. doi: 10.1002/mc.20437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Mellado-Valero A, Ferrer García JC, Herrera Ballester A, Labaig Rueda C. Effects of diabetes on the osseointegration of dental implants. Med Oral Patol Oral Cir Bucal. 2007;12:E38–43. [PubMed] [Google Scholar]
  • 9.Tseng PC, Hou SM, Chen RJ, Peng HW, Hsieh CF, Kuo ML, et al. Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis. J Bone Miner Res. 2011;26:2552–63. doi: 10.1002/jbmr.460. [DOI] [PubMed] [Google Scholar]
  • 10.Kowalski J, Samojedny A, Paul M, Pietsz G, Wilczok T. Effect of apigenin, kaempferol and resveratrol on the expression of interleukin-1beta and tumor necrosis factor-alpha genes in J774.2 macrophages. Pharmacol Rep. 2005;57:390–4. [PubMed] [Google Scholar]

Articles from Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES